| 000 | 01785 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514075222.0 | ||
| 264 | 0 | _c20031104 | |
| 008 | 200311s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/s0145-2126(03)00103-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUllmannová, Veronika | |
| 245 | 0 | 0 |
_aRelationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. _h[electronic resource] |
| 260 |
_bLeukemia research _cDec 2003 |
||
| 300 |
_a1115-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCarcinogens _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCyclin D1 _xgenetics |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aCyclins _xgenetics |
| 650 | 0 | 4 |
_aDNA Primers _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aStöckbauer, Petr | |
| 700 | 1 | _aHradcová, Martina | |
| 700 | 1 | _aSoucek, Josef | |
| 700 | 1 | _aHaskovec, Cedrik | |
| 773 | 0 |
_tLeukemia research _gvol. 27 _gno. 12 _gp. 1115-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0145-2126(03)00103-6 _zAvailable from publisher's website |
| 999 |
_c12694847 _d12694847 |
||